A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4164 (2006.01) A61P 3/00 (2006.01) C12Q 1/02 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2622597
Disclosed are: novel use of an agonist of histamine receptor H3 protein (e.g., Imetit) for the prevention of obesity or the reduction of food intake; a method for evaluation of a compound for use as a therapeutic agent targeted to histamine receptor H3 protein; and a compound provided by the method.
L'invention concerne une nouvelle utilisation d'un agoniste de la protéine du récepteur de l'histamine H3 (par exemple de l'Imetit) pour la prévention de l'obésité ou la réduction de l'absorption d'aliments ; un procédé pour l'évaluation d'un composé destiné à être utilisé comme agent thérapeutique ciblant la protéine du récepteur de l'histamine H3 ; et un composé produit par le procédé.
Ishihara Akane
Kanatani Akio
Tokita Shigeru
Yoshimoto Ryo
Banyu Pharmaceutical Co. Ltd.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Histamine h3 agonist for use as therapeutic agent for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Histamine h3 agonist for use as therapeutic agent for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Histamine h3 agonist for use as therapeutic agent for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1470488